Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
As the year comes to an end, it's time to think about which stocks to sell for tax-loss harvesting. One stock I'm considering letting go is pharma giant (NYSE: PFE). The company's shares have dropped by a whopping 43.5% in 2023, making it a prime candidate for tax-loss harvesting.
And while Pfizer is still a dividend-paying powerhouse and its shares screen as "cheap" based on multiple valuation metrics, I'm losing faith in the company's ability to right the ship, so to speak. Here are two other issues driving me toward hitting the "sell" button on this pharma stock.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Stock
€28.41
0.230%
With 28 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 41 € there is a positive potential of 44.32% for Pfizer Inc. compared to the current price of 28.41 €.
